Heron Therapeutics
NC - CaryBiotechnology
Focus: Heron Therapeutics is a mid-cap biotech focused on polymer-based drug delivery platforms across oncology, gastroenterology, neurology, musculoskeletal, and infectious disease indications. The company generates revenue primarily through commercialized nausea/vomiting and pain management products.
Profile data last refreshed 11h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Heron Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Heron Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Heron Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Late-stage
6 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$142K Part DStable
Peak8.9yr
Help build intelligence for Heron Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.